
Antoine Mariaux
Journalist

Panmure Liberum upgrades its rating on Airbus, but the stock pulls back
Panmure Liberum, in partnership with Agency Partners, says it is upgrading its rating on Airbus shares to 'buy' from 'hold', with a price target raised to 198 from 141. Not enough to convince the market: the stock is down 1.7% in Paris.
July 17, 2026 at 05:35 pm

Panmure Liberum upgrades its Airbus rating, but the stock pulls back
Panmure Liberum, in partnership with Agency Partners, says it is upgrading its recommendation on Airbus to "buy" from "hold", with a price target raised to 198 from 141. That was not enough to win over the market: the stock is down 1.7% in Paris.
July 17, 2026 at 05:19 pm
GSK slides after major camlipixant disappointment
Despite a trial that met its primary endpoint, the overall data package for the drug was judged insufficient to change the standard of care for patients with refractory chronic cough. The disappointment is significant: camlipixant entered GSK's portfolio following its 2023 acquisition of Bellus Health and was then seen as a potential 'multi-blockbuster'. Reflecting dashed hopes, the stock is down 4% in London.
July 17, 2026 at 03:07 pm
ADP shares fall as analysts fear a profit warning
After a June marked by lower traffic at its Paris airports, Groupe ADP cut its annual forecast for traffic growth. The move is fueling fears of an upcoming revision to its 2026 financial targets, flagged by several analysts. By late morning, the stock was down nearly 2% in Paris.
July 17, 2026 at 01:54 pm

Drone Volt picks up speed in the first half and says it is confident about the rest of the year
The French specialist in professional drones posted growth in both activity and gross margin in the first half of 2026, notably thanks to the expansion of higher value-added services. The group says it is entering the second half 'with confidence', supported by solid visibility on its service contracts.
July 16, 2026 at 08:16 pm
Eli Lilly rises after AtaiBeckley purchase deal, RBC supportive
The analyst maintains its 'outperform' rating on Eli Lilly after the acquisition of AtaiBeckley, with an unchanged price target of $1,500. The drugmaker's shares are up more than 1.5% on Wall Street.
July 16, 2026 at 06:10 pm
After its promising results, UnitedHealth is set to jump at the open on Wall Street
Second-quarter 2026 results are sharply higher than last year and above market expectations. The group also raised its full-year adjusted earnings guidance and announced massive share buybacks. Enough to put a smile on investors' faces: the stock is expected to rise by more than 6% at the open on Wall Street.
July 16, 2026 at 02:37 pm

Exail to deliver three light mine countermeasures systems in Europe
The French group specializing in robotics and underwater drones is stepping up its presence in mine warfare with a new reference customer for its light drone solutions designed for shallow-water operations.
July 15, 2026 at 08:13 pm

Indra strengthens its role in rebuilding air traffic management in Ukraine
The Spanish technology group is formalizing new agreements with the Ukrainian authorities to prepare the modernization of air navigation infrastructure and support the protection of critical infrastructure.
July 15, 2026 at 08:03 pm
Discover our authors
Chief Editor
Journalist
Analyst
Journalist
Journalist
- Stock Market
- Our authors
- Antoine Mariaux



























